Gene therapy of B-cell lymphoma with cytokine gene-modified trioma cells

International Journal of Cancer

Volumn 83, Issue 1, 1999, Pages 113-120

  Strehl, John ^a   Selmayr, Michael ^a,b   Kremer, Jean P ^a   Hültner, Lothar ^a   Lindhofer, Horst ^a   Mocikat, Ralph ^a  

^a INSTITUTE OF EPIDEMIOLOGY   (Germany)

^b Bio Rad Laboratories GmbH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GRANULOCYTE COLONY STIMULATING FACTOR; INTERLEUKIN 4;

ANIMAL CELL; ANTIGEN PRESENTING CELL; ARTICLE; B CELL LYMPHOMA; CANCER IMMUNOLOGY; CANCER SURVIVAL; CYTOKINE PRODUCTION; GENE THERAPY; GENE TRANSFER; HUMORAL IMMUNITY; IMMUNOMODULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; ANTIBODIES, BISPECIFIC; ANTIGEN-PRESENTING CELLS; CANCER VACCINES; CLONING, MOLECULAR; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE THERAPY; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; INTERLEUKIN-4; LYMPHOMA, B-CELL; MICE; MICE, INBRED BALB C; TIME FACTORS; TUMOR CELLS, CULTURED;

EID: 0032819910     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19990924)83:1<113::AID-IJC20>3.0.CO;2-J     Document Type: Article

References (22)

1. CELLA, M., SCHEIDEGGER, D., PALMER-LEHMANN, K., LANE, P., LANZAVECCHIA, A. and ALBER, G., Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation. J. exp. Med., 184, 747-752 (1996).
2. CHEN, L., ASHE, S., BRADY, W.A., HELLSTRÖM, I., HELLSTRÖM, K.E., LEDBETTER, J.A., MCGOWAN, P. and LINSLEY, P.S., Costimulation of antitumor immunity by the B7 counterreceptor for the T lymphocyte molecules CD28 and CTLA-4. Cell, 71, 1093-1102 (1992).
3. COULIE, P.G., Human tumour antigens recognized by T cells: new perspectives for anti-cancer vaccines? Mol. Med. Today, 3, 261-268 (1997).
4. DRANOFF, G., JAFFEE, E., LAZENBY, A., GOLUMBEK, P., LEVITSKY, H., BROSE, K., JACKSON, V., HAMADA, H., PARDOLL, D. and MULLIGAN, R.C., Vaccination with irradiated tumour cells engineered to secrete murine granulocytemacrophage colony-stimulating factor stimulates potent, specific and long-lasting anti-tumour immunity. Proc. natl. Acad. Sci. (Wash.), 90, 3539-3543 (1993).
5. GLIMCHER, L.H., KIM, K.-J., GREEN, J. and PAUL, W.E., Ia antigen-bearing B cell tumour lines can present protein antigen and alloantigen in a major histocompatibility complex-restricted fashion to antigen-reactive T cells. J. exp. Med., 155, 445-459 (1982).
6. GRUNEWALD, S.M., KUNZMANN, S., SCHNARR, B., EZERNIEKS, J., SEBALD, W. and DUSCHL, A., A murine interleukin-4 antagonistic mutant protein completely inhibits interleukin-4-induced cell proliferation, differentiation and signal transduction. J. biol. Chem., 272, 1480-1483 (1997).
7. KARASUYAMA, H., KUDO, A. and MELCHERS, F., The proteins encoded by the VpreB and λ5 pre-B cell-specific genes can associate with each other and with μ heavy chain. J. Exp. Med. 172, 969-972 (1990).
8. KOCH, F., STANZL, U., JENNEWEIN, P., JANKE, K., HEUFLER, C., KAMPGEN, E., ROMANI, N. and SCHULER, G., High level IL-12 production by murine dendritic cells: upregulation via MHC class II and CD40 molecules and downregulation by IL-4 and IL-10. J. exp. Med., 184, 741-746 (1996).
9. LEVITSKY, H.I., MONTGOMERY, J., AHMADZADEH, M., STAVELEY-O'CARROLL, K., GUARNIERI, F., LONGO, D.L. and KWAK, L.W., Immunisation with granulocyte-macrophage colony-stimulating factor-transduced, but not B7-1-transduced, lymphoma cells primes idiotype-specific T cells and generates potent systemic antitumor immunity. J. Immunol., 156, 3858-3865 (1996).
10. LINDHOFER, H., MOCIKAT, R., STEIPE, B. and THIERFELDER, S., Preferential species-restricted heavy/light chain pairing in rat/mouse quadromas. J. Immunol., 155, 219-225 (1995).
11. MACATONIA, S.E., HOSKEN, N.A., LITTON, M., VIEIRA, P., HSIEH, C.S., CULPEPPER, J.A., WYSOCKA, M., TRINCHIERI, G., MURPHY, K.M. and O'GARRA, A., Dendritic cells produce IL-12 and direct the development of TH1 cells from naive CD4+ T cells. J. Immunol., 154, 5071-5079 (1995).
12. MOCIKAT, R., KÜTEMEIER, G., HOFFMANN-FEZER, G. and THIERFELDER, S., A mouse model for the preclinical evaluation of immunosuppressive effector functions of human isotypes. The human IgG1 isotype is superior to IgG3. Transplantation, 57, 405-411 (1994).
13. MOCIKAT, R., SELMAYR, M., THIERFELDER, S. and LINDHOFER, H., Trioma-based vaccination against B-cell lymphoma confers long-lasting tumour immunity. Cancer Res., 57, 2346-2349 (1997).
14. MÜLLER, W., KÜHN, R. and RAJEWSKY, K., Major histocompatibility complex class II hyperexpression on B cells in interleukin 4-transgenic mice does not lead to B cell proliferation and hypergammaglobulinemia. Europ. J. Immunol., 21, 921-925 (1991).
15. MULLIGAN, R.C. and BERG, P., Selection for animal cells that express the Escherichia coli gene coding for xanthine-guanine phosphoribosyltransferase. Proc. natl. Acad. Sci. (Wash.), 78, 2072-2076 (1981).
16. NAPARSTEK, E., PIERCE, J., METCALF, D., SHADDUCK, R., IHLE, J., LEDER, A., SAKAKEENY, M.A., WAGNER, K., FALCO, J., FITZGERALD, T.J. and GREENBERGER, J.S., Induction of growth alterations in factor-dependent hematopoietic progenitor cell lines by cocultivation with irradiated bone marrow stromal cell lines. Blood, 67, 1395-1403 (1986).
17. SCHMIDT, W., SCHWEIGHOFFER, T., HERBST, E., MAASS, G., BERGER, M., SCHILDER, F., SCHAFFNER, G. and BIRNSTIEL, M.L., Cancer vaccines: the interleukin 2 dosage effect. Proc. natl. Acad. Sci. (Wash.), 92, 4711-4714 (1995).
18. SCHMIDT-WOLF, G. and SCHMIDT-WOLF, I.G.H., Cytokines and clinical gene therapy. Europ. J. Immunol., 25, 1137-1140 (1995).
19. SCHWARTZ, R.H., A cell culture model for T lymphocyte clonal anergy. Science, 248, 1349-1356 (1990).
20. TEPPER, R.I. and MULE, J.J., Experimental and clinical studies of cytokine gene-modified tumour cells. Hum. Gene Ther., 5, 153-164 (1994).
21. TSIOULIAS, G.J., TRIADAFILOPOULOS, G., GOLDIN, E., PAPAVASSILIOU, E.D., RIZOS, S., BASSIOUKAS, P. and RIGAS, B., Expression of HLA class I antigens in sporadic adenomas and histologically normal mucosa of the colon. Cancer Res., 53, 2374-2378 (1993).
22. UYTTENHOVE, C., SIMPSON, R.J. and VAN SNICK, J., Functional and structural characterization of P40, a mouse glycoprotein with T cell growth factor activity. Proc. natl. Acad. Sci. (Wash.), 85, 6934-6938 (1988).